Literature DB >> 11436176

Review article: Regulation of glucose production with special attention to nonclassical regulatory mechanisms: a review.

E P Corssmit1, J A Romijn, H P Sauerwein.   

Abstract

Hepatic glycogenolysis and gluconeogenesis are essential processes for the prevention of hypoglycemia during short-term starvation. As has been calculated from stable isotope studies, gluconeogenesis accounts for approximately 35% to 50% of total basal glucose production, glycogenolysis for the other 50% to 65%. In long-term starvation, the kidney also contributes to glucose production by gluconeogenesis. Glucose production is regulated by the interaction of different regulatory mechanisms, eg, by glucoregulatory hormones, glucose itself, and gluconeogenic substrates. In the last decades, more insight has been gained into the importance of the autonomous nervous system and the existence of an extensive paracrine network in the liver that seems to exert a potent glucoregulatory role as well. This review is focused on the regulation of hepatic glucose production by the autonomous nervous system and the paracrine network, with special emphasis on studies carried out in human subjects. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11436176     DOI: 10.1053/meta.2001.24195

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  15 in total

1.  Sequential changes in the expression of genes involved in lipid metabolism in adipose tissue and liver in response to fasting.

Authors:  M Palou; T Priego; J Sánchez; E Villegas; A M Rodríguez; A Palou; C Picó
Journal:  Pflugers Arch       Date:  2008-05-21       Impact factor: 3.657

2.  Gluconeogenesis: An ancient biochemical pathway with a new twist.

Authors:  Tetsuya Miyamoto; Hubert Amrein
Journal:  Fly (Austin)       Date:  2017-01-25       Impact factor: 2.160

3.  Neurolysin knockout mice generation and initial phenotype characterization.

Authors:  Diogo M L P Cavalcanti; Leandro M Castro; José C Rosa Neto; Marilia Seelaender; Rodrigo X Neves; Vitor Oliveira; Fábio L Forti; Leo K Iwai; Fabio C Gozzo; Mihail Todiras; Ines Schadock; Carlos C Barros; Michael Bader; Emer S Ferro
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

4.  MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes.

Authors:  Mark D Erion; Paul D van Poelje; Qun Dang; Srinivas Rao Kasibhatla; Scott C Potter; M Rami Reddy; K Raja Reddy; Tao Jiang; William N Lipscomb
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

5.  The insulin gene as an energy homeostasis biomarker in Yangtze sturgeon (Acipenser dabryanus).

Authors:  Xin Zhang; Hu Chen; Ya Li; Ni Tang; Defang Chen; Zhiqiong Li
Journal:  Fish Physiol Biochem       Date:  2022-05-03       Impact factor: 2.794

6.  Fasting adaptation in idiopathic ketotic hypoglycemia: a mismatch between glucose production and demand.

Authors:  Hidde H Huidekoper; Marinus Duran; Marjolein Turkenburg; Mariëtte T Ackermans; Hans P Sauerwein; Frits A Wijburg
Journal:  Eur J Pediatr       Date:  2007-10-13       Impact factor: 3.183

Review 7.  Insulin therapy for the management of hyperglycemia in hospitalized patients.

Authors:  Marie E McDonnell; Guillermo E Umpierrez
Journal:  Endocrinol Metab Clin North Am       Date:  2012-02-17       Impact factor: 4.741

8.  Circadian control of the daily plasma glucose rhythm: an interplay of GABA and glutamate.

Authors:  Andries Kalsbeek; Ewout Foppen; Ingrid Schalij; Caroline Van Heijningen; Jan van der Vliet; Eric Fliers; Ruud M Buijs
Journal:  PLoS One       Date:  2008-09-15       Impact factor: 3.240

9.  The transcriptomic signature of fasting murine liver.

Authors:  Milka Sokolović; Aleksandar Sokolović; Diederik Wehkamp; Emiel Ver Loren van Themaat; Dirk R de Waart; Lisa A Gilhuijs-Pederson; Yuri Nikolsky; Antoine H C van Kampen; Theodorus B M Hakvoort; Wouter H Lamers
Journal:  BMC Genomics       Date:  2008-11-06       Impact factor: 3.969

10.  Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized Patients.

Authors:  Carlos E Mendez; Guillermo E Umpierrez
Journal:  Diabetes Spectr       Date:  2014-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.